THNR vs. KNGS ETF Comparison
Comparison of Amplify Weight Loss Drug & Treatment ETF (THNR) to Roundhill S&P Dividend Monarchs ETF (KNGS)
THNR
Amplify Weight Loss Drug & Treatment ETF
THNR Description
The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business. GLP-1 agonists (glucagon-like peptide) seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$23.22
Average Daily Volume
2,604
15
KNGS
Roundhill S&P Dividend Monarchs ETF
KNGS Description
The fund generally invests in securities that Upholdings believes have the potential to compound at a higher rate than the S&P 500 Index over multi-year periods. It will invest at least 60% of its total net assets in equity securities of companies of medium and large market capitalizations located in both the United States. The fund will also invest in other international markets, including emerging markets. It is non-diversified.Grade (RS Rating)
Last Trade
$28.64
Average Daily Volume
1,134
10
Performance
| Period | THNR | KNGS |
|---|---|---|
| 30 Days | -11.49% | -3.04% |
| 60 Days | -15.44% | -2.82% |
| 90 Days | -16.31% | -0.75% |
| 12 Months | 9.95% |
0 Overlapping Holdings
| Symbol | Grade | Weight in THNR | Weight in KNGS | Overlap |
|---|
THNR: Top Represented Industries & Keywords
KNGS: Top Represented Industries & Keywords
Compare ETFs
